# Clopidogrel Preventive Effect Based on CYP2C19 Genotype in Ischemic Stroke

> **NCT04072705** · — · COMPLETED · sponsor: **Gangnam Severance Hospital** · enrollment: 2927 (actual)

## Conditions studied

- Acute Ischemic Stroke

## Interventions

- **DRUG:** General principles of care and judgement of researcher

## Key facts

- **NCT ID:** NCT04072705
- **Lead sponsor:** Gangnam Severance Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2019-09-20
- **Primary completion:** 2023-01-11
- **Final completion:** 2023-07-07
- **Target enrollment:** 2927 (ACTUAL)
- **Last updated:** 2023-09-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04072705

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04072705, "Clopidogrel Preventive Effect Based on CYP2C19 Genotype in Ischemic Stroke". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04072705. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*